Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00162370 · ClinicalTrials.gov registry record · Phase 4
A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
NCT00162370 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 400 participants.
The verdict
NCT00162370, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
Study Summary
The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
Interventions
- DRUG Perflutren Lipid Microsphere Injectable Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00162370
The ClinicalTrials.gov registry entry for NCT00162370 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perflutren Lipid Microsphere Injectable Suspension is the first listed.
NCT00162370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00162370 about?
NCT00162370 is a clinical study titled "A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease". The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
What is the current status of trial NCT00162370?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2004-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00162370?
The interventions under investigation include: Perflutren Lipid Microsphere Injectable Suspension (DRUG).
Who is sponsoring clinical trial NCT00162370?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.